CIK 0001661053 · Non-accelerated filer<br>Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330936180
- Phone
- 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-13 | Jenusaitis Matthew Director | Grant or award · Restricted Stock Units | +78,125 | 78,125 | ||
| 2019-09-13 | Jenusaitis Matthew Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-09-13 | Gray Robert Director | Grant or award · Restricted Stock Units | +78,125 | 78,125 | ||
| 2019-09-13 | Gray Robert Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-07-26 | Glickman Marc H. CMO and Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −184,500 | 0 | ||
| 2019-07-26 | Glickman Marc H. CMO and Senior Vice President | Grant or award · Stock Option (Right to Buy) | +184,500 | 184,500 | ||
| 2019-07-26 | Glickman Marc H. CMO and Senior Vice President | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2019-06-07 | Biodyne Holding, S.A. 10% owner | Sale | −684,813 | $0.67 | $459K | 3,581,016 |
| 2019-05-21 | Biodyne Holding, S.A. 10% owner | Other disposition | −177,740 | 4,265,829 | ||
| 2019-03-12 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +18,382 | $1.36 | $25K | 18,382 |
| 2019-03-12 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +21,740 | $1.15 | $25K | 21,740 |
| 2018-11-27 | Shrivastava Sanjay Director | Grant or award · Restricted Stock Units | +29,183 | 29,183 | ||
| 2018-11-27 | Shrivastava Sanjay Director | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2018-11-27 | Duhay Francis Director | Grant or award | +29,183 | $2.57 | $75K | 29,183 |
| 2018-11-27 | Duhay Francis Director | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2018-11-27 | Robins Marcus W. Director | Grant or award | +29,183 | $2.57 | $75K | 29,183 |
| 2018-11-27 | Robins Marcus W. Director | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2018-11-27 | Shrivastava Sanjay Director | Grant or award | +29,183 | $2.57 | $75K | 29,183 |
| 2018-11-27 | Shrivastava Sanjay Director | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2018-11-27 | Broennimann Benedict Chief Medical Officer, OUS | Grant or award | +3,334 | 437,778 |
Page 7 of 8 · 141 trades